Gp Act Iii Acquisition Stock Performance
| GPAT Stock | 10.12 0.01 0.1% |
GP Act has a performance score of 15 on a scale of 0 to 100. The company owns a Beta (Systematic Risk) of 0.0342, which attests to not very significant fluctuations relative to the market. As returns on the market increase, GP Act's returns are expected to increase less than the market. However, during the bear market, the loss of holding GP Act is expected to be smaller as well. GP Act III today owns a risk of 0.0903%. Please check out GP Act III Acquisition standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to decide if GP Act III Acquisition will be following its current price history.
Risk-Adjusted Performance
15 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in GP Act III Acquisition are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, GP Act is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Actual Historical Performance (%)
Five Day Return 0.4 | Year To Date Return 1.3 | Ten Year Return 1.3 | All Time Return 1.3 |
1 | Glazer Capital LLC Invests 2.76 Million in GP-Act III Acquisition Corp. - Defense World | 09/24/2024 |
2 | MMCAP International Inc. SPC Acquires New Stake in GP-Act III Acquisition Corp | 11/07/2024 |
3 | Polar Asset Management Partners Inc. Acquires New Stake in GP-Act III Acquisition Corp | 11/14/2024 |
4 | First Trust Capital Management L.P. Acquires New Stake in GP-Act III Acquisition Corp | 11/15/2024 |
| Begin Period Cash Flow | 1758.00 |
GPAT |
GP Act Relative Risk vs. Return Landscape
If you would invest 1,001 in GP Act III Acquisition on August 31, 2024 and sell it today you would earn a total of 11.00 from holding GP Act III Acquisition or generate 1.1% return on investment over 90 days. GP Act III Acquisition is currently generating 0.0174% in daily expected returns and assumes 0.0903% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than GPAT, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
GP Act Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for GP Act's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as GP Act III Acquisition, and traders can use it to determine the average amount a GP Act's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1926
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| GPAT |
Based on monthly moving average GP Act is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GP Act by adding it to a well-diversified portfolio.
GP Act Fundamentals Growth
GPAT Stock prices reflect investors' perceptions of the future prospects and financial health of GP Act, and GP Act fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GPAT Stock performance.
| Current Valuation | 363.57 M | ||||
| Shares Outstanding | 28.75 M | ||||
| Price To Book | 1.30 X | ||||
| EBITDA | (14.04 K) | ||||
| Net Income | (14.04 K) | ||||
| Total Debt | 628.18 K | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (10.97 K) | ||||
| Earnings Per Share | 0.15 X | ||||
| Market Capitalization | 363.69 M | ||||
| Total Asset | 530.24 K | ||||
| Retained Earnings | (122.94 K) | ||||
| Working Capital | (624.87 K) | ||||
About GP Act Performance
Assessing GP Act's fundamental ratios provides investors with valuable insights into GP Act's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the GP Act is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.03) | (0.03) | |
| Return On Capital Employed | 0.14 | 0.09 | |
| Return On Assets | (0.03) | (0.03) | |
| Return On Equity | 0.14 | 0.09 |
Things to note about GP Act III performance evaluation
Checking the ongoing alerts about GP Act for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for GP Act III help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| GP Act III has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (14.04 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| GP Act generates negative cash flow from operations | |
| GP Act III has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: First Trust Capital Management L.P. Acquires New Stake in GP-Act III Acquisition Corp |
- Analyzing GP Act's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether GP Act's stock is overvalued or undervalued compared to its peers.
- Examining GP Act's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating GP Act's management team can have a significant impact on its success or failure. Reviewing the track record and experience of GP Act's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of GP Act's stock. These opinions can provide insight into GP Act's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.